Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Clinical Nuclear Medicine|October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinibDeniz Kahraman, Arne Holstein, Matthias Scheffler, et al.
Scientific Reports|October 28, 2020
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survivalHeike Loeser, Matthias Scholz, Hans Fuchs, et al.
Scientific Reports|August 7, 2025
The expression of the tight junction protein and therapeutical target Claudin 18.2 is heterogeneously distributed within esophageal and gastric adenocarcinomaSvetlana Pak, Adrian Georg Simon, Su Ir Lyu, et al.
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
Cancer Research|May 14, 2009
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"Marc Beyer, Julia Karbach, Michael R Mallmann, et al.
Molecular and Clinical Oncology|August 8, 2017
Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinomaHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Blood|July 24, 2007
RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphomaJens M Chemnitz, Daniela Eggle, Julia Driesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditionsSabine Classen, Thomas Zander, Daniela Eggle, et al.
Cancers|October 14, 2022
Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the EsophagusSascha Hoppe, Lydia Meder, Florian Gebauer, et al.
Annals of Surgical Oncology|May 21, 2023
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric JunctionFlorian Gebauer, Patrick S Plum, Alexander Damanakis, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Clinical Nuclear Medicine|October 3, 2012
Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinibDeniz Kahraman, Arne Holstein, Matthias Scheffler, et al.
Scientific Reports|October 28, 2020
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survivalHeike Loeser, Matthias Scholz, Hans Fuchs, et al.
Scientific Reports|August 7, 2025
The expression of the tight junction protein and therapeutical target Claudin 18.2 is heterogeneously distributed within esophageal and gastric adenocarcinomaSvetlana Pak, Adrian Georg Simon, Su Ir Lyu, et al.
The Oncologist|January 10, 2013
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphomaNils Schoof, Jeremy Franklin, Robert Fürst, et al.
Cancer Research|May 14, 2009
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"Marc Beyer, Julia Karbach, Michael R Mallmann, et al.
Molecular and Clinical Oncology|August 8, 2017
Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinomaHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Blood|July 24, 2007
RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphomaJens M Chemnitz, Daniela Eggle, Julia Driesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditionsSabine Classen, Thomas Zander, Daniela Eggle, et al.
Cancers|October 14, 2022
Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the EsophagusSascha Hoppe, Lydia Meder, Florian Gebauer, et al.
Annals of Surgical Oncology|May 21, 2023
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric JunctionFlorian Gebauer, Patrick S Plum, Alexander Damanakis, et al.
Pageof 21